In the fourth quarter, Kawa Capital Management disclosed a new position in Alexandria Real Estate Equities, acquiring 160,000 shares valued at approximately $7.93 million. This stake now represents 18.3 percent of the firm’s reportable U.S. equity assets under management, making ARE its third-largest holding behind two other core positions. The timing follows a nearly 40 percent share decline over the past year, suggesting the fund’s managers view current valuations as an attractive entry point into the life-science-focused REIT.

Alexandria Real Estate Equities generated nearly $3 billion in revenue over the trailing twelve months, though it reported a net loss of $410.9 million due to asset dispositions and higher financing costs. Adjusted funds from operations reached $2.22 per share in the third quarter and $6.85 year-to-date, underpinning a dividend yield above 8 percent. The company maintains 90.6 percent occupancy across its campus portfolio, 97 percent of leases include annual rent escalators, and the weighted average lease term stands at 7.5 years. Liquidity remains ample at $4.2 billion, with only 7 percent of debt maturing through 2027.

Management has extended a $500 million share repurchase authorization through 2026, with $241.8 million still available, signaling confidence in the balance sheet while share prices remain depressed. Recent non-core asset sales and disciplined capital allocation aim to bolster profitability and reduce leverage ahead of new developments expected to contribute about $240 million in incremental net operating income from 2027 onward. For investors, the new concentrated stake by Kawa Capital underscores a bet on durable rental income, strong tenant retention, and a recovery in life-science leasing that is sustainable over the long term.